Testy testy. I think vein has a good and valid point. At almost 4 bucks a share I would say at this time he really doesn’t know what he is doing. Or if he knows what he is doing, it is not working too well. The business side and the share price go hand in hand. He is too concerned about the science side.
What an obnoxious post. “Focused on business” you say? Where’s the evidence to support that claim? The company predicts revenue every year since 2008 and fails to deliver each and every year. Stock drops from $20 to nearly $3, and you think Vein is whining?
I respectfully suggest that any long who isn’t whining at this point is brain dead.
News 
Market Data 
Discover 
